Richard Malamut - 12 Sep 2024 Form 4 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
Director
Signature
/s/ Francis Knuettel II, under Power of Attorney dated August 1, 2023, from Richard Malamut
Issuer symbol
CHRO
Transactions as of
12 Sep 2024
Net transactions value
+$9,825
Form type
4
Filing time
16 Sep 2024, 16:56:55 UTC
Previous filing
18 Jun 2024
Next filing
15 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRO Common Stock Purchase $9,825 +10,400 +13% $0.9447 91,565 12 Sep 2024 Jointly held with spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the weighted average price of the shares purchased ranging from $0.9206 to $0.9554 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.